المؤلفون: van der Kruijssen DEW; Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, Utrecht., Elias SG; Department of Epidemiology, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht., van de Ven PM; Department of Epidemiology, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht., van Rooijen KL; Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, Utrecht., Lam-Boer J'; Department of Surgery, Radboud University Medical Center, Nijmegen; Department of Surgery, Netherlands Cancer Institute, Amsterdam., Mol L; Clinical Research Department, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht., Punt CJA; Department of Epidemiology, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht., Sommeijer DW; Department of Medical Oncology, Amsterdam University Medical Center, Amsterdam; Department of Medical Oncology, Flevo Hospital, Almere., Tanis PJ; Department of Surgery, Amsterdam University Medical Center, Amsterdam; Department of Surgery, Erasmus Medical Center, Rotterdam, The Netherlands., Nielsen JD; Department of Surgery, Aalborg University Hospital, Aalborg, Denmark., Yilmaz MK; Department of Medical Oncology, Aalborg University Hospital, Aalborg, Denmark., van Riel JMGH; Department of Medical Oncology, Elisabeth-TweeSteden Hospital, Tilburg., Wasowiz-Kemps DK; Department of Surgery, Elisabeth-TweeSteden Hospital, Tilburg., Loosveld OJL; Department of Medical Oncology, Amphia Hospital, Breda., van der Schelling GP; Department of Surgery, Amphia Hospital, Breda., de Groot JWB; Department of Medical Oncology, Isala Hospital, Zwolle, The Netherlands., van Westreenen HL; Department of Surgery, Isala Hospital, Zwolle, The Netherlands., Jakobsen HL; Department of Surgery, Herlev and Gentofte Hospital, Herlev, Denmark., Fromm AL; Department of Medical Oncology, Herlev and Gentofte Hospital, Herlev, Denmark., Hamberg P; Department of Medical Oncology, Franciscus Gasthuis & Vlietland, Rotterdam, The Netherlands., Verseveld M; Department of Surgery, Franciscus Gasthuis & Vlietland, Rotterdam, The Netherlands., Jaensch C; Department of Surgery, Regional Hospital Gødstrup, Herning, Denmark., Liposits GI; Department of Medical Oncology, Regional Hospital Gødstrup, Herning, Denmark., van Duijvendijk P; Department of Surgery, Gelre Hospital, Apeldoorn., Oulad Hadj J; Department of Medical Oncology, Gelre Hospital, Apeldoorn., van der Hoeven JAB; Department of Surgery, Albert Schweitzer Hospital, Dordrecht, The Netherlands., Trajkovic M; Department of Medical Oncology, Albert Schweitzer Hospital, Dordrecht, The Netherlands., de Wilt JHW; Department of Surgery, Radboud University Medical Center, Nijmegen., Koopman M; Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, Utrecht. Electronic address: M.Koopman-6@umcutrecht.nl.

مؤلفون مشاركون: CAIRO4 Working Group

المصدر: Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2024 Sep; Vol. 35 (9), pp. 769-779. Date of Electronic Publication: 2024 Jun 07.

نوع المنشور: Journal Article; Clinical Trial, Phase III; Randomized Controlled Trial; Multicenter Study

بيانات الدورية: Publisher: Elsevier Country of Publication: England NLM ID: 9007735 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1569-8041 (Electronic) Linking ISSN: 09237534 NLM ISO Abbreviation: Ann Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Colorectal Neoplasms*/pathology , Colorectal Neoplasms*/drug therapy , Colorectal Neoplasms*/surgery , Colorectal Neoplasms*/mortality , Antineoplastic Combined Chemotherapy Protocols*/therapeutic use, Humans ; Male ; Female ; Aged ; Middle Aged ; Denmark/epidemiology ; Netherlands/epidemiology ; Bevacizumab/administration & dosage ; Bevacizumab/therapeutic use ; Neoplasms, Multiple Primary/surgery ; Neoplasms, Multiple Primary/pathology ; Neoplasms, Multiple Primary/drug therapy ; Neoplasms, Multiple Primary/mortality ; Aged, 80 and over ; Adult ; Neoplasm Metastasis ; Survival Rate

المؤلفون: Calmels L; Department of Oncology, Copenhagen University Hospital - Herlev and Gentofte, Copenhagen, Denmark., Sibolt P; Department of Oncology, Copenhagen University Hospital - Herlev and Gentofte, Copenhagen, Denmark., Åström LM; Department of Oncology, Copenhagen University Hospital - Herlev and Gentofte, Copenhagen, Denmark.; Department of Health Technology, Technical University of Denmark, Roskilde, Denmark., Serup-Hansen E; Department of Oncology, Copenhagen University Hospital - Herlev and Gentofte, Copenhagen, Denmark., Lindberg H; Department of Oncology, Copenhagen University Hospital - Herlev and Gentofte, Copenhagen, Denmark., Fromm AL; Department of Oncology, Copenhagen University Hospital - Herlev and Gentofte, Copenhagen, Denmark., Persson G; Department of Oncology, Copenhagen University Hospital - Herlev and Gentofte, Copenhagen, Denmark.; Department of Clinical Oncology, Copenhagen University, Copenhagen, Denmark., Sjöström D; Department of Oncology, Copenhagen University Hospital - Herlev and Gentofte, Copenhagen, Denmark., Geertsen P; Department of Oncology, Copenhagen University Hospital - Herlev and Gentofte, Copenhagen, Denmark., Behrens CP; Department of Oncology, Copenhagen University Hospital - Herlev and Gentofte, Copenhagen, Denmark.; Department of Health Technology, Technical University of Denmark, Roskilde, Denmark.

المصدر: Technical innovations & patient support in radiation oncology [Tech Innov Patient Support Radiat Oncol] 2022 Apr 12; Vol. 22, pp. 30-36. Date of Electronic Publication: 2022 Apr 12 (Print Publication: 2022).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier B.V Country of Publication: England NLM ID: 101762366 Publication Model: eCollection Cited Medium: Internet ISSN: 2405-6324 (Electronic) Linking ISSN: 24056324 NLM ISO Abbreviation: Tech Innov Patient Support Radiat Oncol Subsets: PubMed not MEDLINE

المؤلفون: Larsen FO; Department of Oncology, Copenhagen University Hospital, Herlev-Gentofte, Herlev, Denmark. Electronic address: Finn.Ole.Larsen@regionh.dk., Markussen A; Department of Oncology, Copenhagen University Hospital, Herlev-Gentofte, Herlev, Denmark., Jensen BV; Department of Oncology, Copenhagen University Hospital, Herlev-Gentofte, Herlev, Denmark., Fromm AL; Department of Oncology, Copenhagen University Hospital, Herlev-Gentofte, Herlev, Denmark., Vistisen KK; Department of Oncology, Copenhagen University Hospital, Herlev-Gentofte, Herlev, Denmark., Parner VK; Department of Oncology, Copenhagen University Hospital, Herlev-Gentofte, Herlev, Denmark., Linnemann D; Department of Pathology, Copenhagen University Hospital, Herlev-Gentofte, Herlev, Denmark., Hansen RH; Department of Radiology, Copenhagen University Hospital, Herlev-Gentofte, Herlev, Denmark., Johannesen HH; Department of Radiology, Copenhagen University Hospital, Herlev-Gentofte, Herlev, Denmark., Schou JV; Department of Oncology, Copenhagen University Hospital, Herlev-Gentofte, Herlev, Denmark.

المصدر: Clinical colorectal cancer [Clin Colorectal Cancer] 2017 Jun; Vol. 16 (2), pp. e7-e14. Date of Electronic Publication: 2016 Sep 14.

نوع المنشور: Clinical Trial, Phase II; Journal Article

بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 101120693 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1938-0674 (Electronic) Linking ISSN: 15330028 NLM ISO Abbreviation: Clin Colorectal Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Combined Chemotherapy Protocols/*therapeutic use , Chemoradiotherapy/*methods , Radiotherapy, Intensity-Modulated/*methods , Rectal Neoplasms/*therapy, Adult ; Aged ; Capecitabine/administration & dosage ; Disease-Free Survival ; Female ; Humans ; Magnetic Resonance Imaging/methods ; Male ; Middle Aged ; Organoplatinum Compounds/administration & dosage ; Oxaliplatin ; Prospective Studies ; Rectal Neoplasms/diagnostic imaging ; Rectal Neoplasms/pathology

المؤلفون: Larsen FO; Department of Oncology, Herlev Hospital, University of Copenhagen, Denmark. olelar02@heh.regionh.dk, Boisen MK, Fromm AL, Jensen BV

المصدر: Acta oncologica (Stockholm, Sweden) [Acta Oncol] 2012 Feb; Vol. 51 (2), pp. 231-3. Date of Electronic Publication: 2011 Sep 22.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Informa Healthcare Country of Publication: England NLM ID: 8709065 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1651-226X (Electronic) Linking ISSN: 0284186X NLM ISO Abbreviation: Acta Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Combined Chemotherapy Protocols/*therapeutic use , Colorectal Neoplasms/*drug therapy, Aged ; Aged, 80 and over ; Antibodies, Monoclonal, Humanized/administration & dosage ; Antibodies, Monoclonal, Humanized/adverse effects ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Bevacizumab ; Capecitabine ; Colorectal Neoplasms/pathology ; Deoxycytidine/administration & dosage ; Deoxycytidine/adverse effects ; Deoxycytidine/analogs & derivatives ; Disease-Free Survival ; Female ; Fluorouracil/administration & dosage ; Fluorouracil/adverse effects ; Fluorouracil/analogs & derivatives ; Humans ; Male ; Middle Aged ; Retrospective Studies ; Survival Analysis ; Treatment Outcome

المؤلفون: Larsen FO; Department of Oncology, Herlev Hospital, University of Copenhagen, Denmark. olelar02@heh.regionh.dk, Pfeiffer P, Nielsen D, Skougaard K, Qvortrup C, Vistisen K, Fromm AL, Jørgensen TL, Bjerregaard JK, Hoegdall E, Jensen BV

المصدر: Acta oncologica (Stockholm, Sweden) [Acta Oncol] 2011 May; Vol. 50 (4), pp. 574-7.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Informa Healthcare Country of Publication: England NLM ID: 8709065 Publication Model: Print Cited Medium: Internet ISSN: 1651-226X (Electronic) Linking ISSN: 0284186X NLM ISO Abbreviation: Acta Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Combined Chemotherapy Protocols/*therapeutic use , Colorectal Neoplasms/*drug therapy , Liver Neoplasms/*drug therapy, Adult ; Aged ; Aged, 80 and over ; Antibodies, Monoclonal/administration & dosage ; Antibodies, Monoclonal, Humanized ; Bevacizumab ; Camptothecin/administration & dosage ; Camptothecin/analogs & derivatives ; Cetuximab ; Colorectal Neoplasms/genetics ; Colorectal Neoplasms/pathology ; Female ; Humans ; Irinotecan ; Liver Neoplasms/genetics ; Liver Neoplasms/secondary ; Male ; Middle Aged ; Mutation/genetics ; Proto-Oncogene Proteins/genetics ; Proto-Oncogene Proteins p21(ras) ; Retrospective Studies ; Survival Rate ; Treatment Outcome ; ras Proteins/genetics

المؤلفون: Fromm AL; University of South Florida, 3951 Versailles Drive, Tampa, FL 33634, USA. afromm@health.usf.edu

المصدر: Gastroenterology nursing : the official journal of the Society of Gastroenterology Nurses and Associates [Gastroenterol Nurs] 2009 Nov-Dec; Vol. 32 (6), pp. 393-8; quiz 399-400.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 8915377 Publication Model: Print Cited Medium: Internet ISSN: 1538-9766 (Electronic) Linking ISSN: 1042895X NLM ISO Abbreviation: Gastroenterol Nurs

مواضيع طبية MeSH: Helicobacter pylori*/isolation & purification, Helicobacter Infections/*nursing, Aged ; Aged, 80 and over ; Anti-Bacterial Agents/therapeutic use ; Anti-Infective Agents/therapeutic use ; Anti-Infective Agents, Local/therapeutic use ; Antidiarrheals/therapeutic use ; Bismuth/therapeutic use ; Breath Tests ; Carcinoma/microbiology ; Carcinoma/prevention & control ; Drug Therapy, Combination ; Early Diagnosis ; Florida/epidemiology ; Helicobacter Infections/complications ; Helicobacter Infections/diagnosis ; Helicobacter Infections/drug therapy ; Helicobacter Infections/epidemiology ; Humans ; Organometallic Compounds/therapeutic use ; Peptic Ulcer/microbiology ; Peptic Ulcer/prevention & control ; Population Surveillance ; Practice Guidelines as Topic ; Prevalence ; Randomized Controlled Trials as Topic ; Risk Factors ; Salicylates/therapeutic use ; Stomach Neoplasms/microbiology ; Stomach Neoplasms/prevention & control ; Treatment Outcome